Wird geladen...
Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice
Recent clinical trials have demonstrated that combination therapy with renin-angiotensin system inhibitors plus calcium channel blockers (CCBs) elicits beneficial effects on cardiovascular and renal events in hypertensive patients with high cardiovascular risks. In the present study, we hypothesized...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Public Library of Science
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3858271/ https://ncbi.nlm.nih.gov/pubmed/24339994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0082082 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|